 | • レポートコード：QFJ1-6042 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、チゲサイクリン薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（チゲサイクリン、ジェネリック）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・チゲサイクリン薬の市場動向 ・企業の競争状況、市場シェア ・チゲサイクリン薬の種類別市場規模と予測2016-2027（チゲサイクリン、ジェネリック） ・チゲサイクリン薬の用途別市場規模と予測2016-2027（病院、ドラッグストア） ・チゲサイクリン薬の北米市場規模2016-2027（アメリカ、カナダ） ・チゲサイクリン薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・チゲサイクリン薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・チゲサイクリン薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・チゲサイクリン薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Sandoz、Apotex、Fresenius Kabi、Accord Healthcare、Amneal、Zhejiang Hisun Pharmaceutical、Nanjing Hicin Pharmaceutical、CTTQ Pharma） ・結論 |
Tigecycline is an antibiotic for a number of bacterial infections. It is a glycylcycline administered intravenously. It was developed in response to the growing rate of antibiotic resistant bacteria such as Staphylococcus aureus, Acinetobacter baumannii, and E. coli.
Market Analysis and Insights: Global Tigecycline Drug Market
The global Tigecycline Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Tigecycline Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Tigecycline Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Tigecycline Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Tigecycline Drug market.
Global Tigecycline Drug Scope and Market Size
Tigecycline Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tigecycline Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
TYGACIL
Generic
Segment by Application
Hospital
Drug store
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Sandoz
Apotex
Fresenius Kabi
Accord Healthcare
Amneal
Zhejiang Hisun Pharmaceutical
Nanjing Hicin Pharmaceutical
CTTQ Pharma
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tigecycline Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 TYGACIL
1.2.3 Generic
1.3 Market by Application
1.3.1 Global Tigecycline Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Drug store
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Tigecycline Drug Market Perspective (2016-2027)
2.2 Tigecycline Drug Growth Trends by Regions
2.2.1 Tigecycline Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Tigecycline Drug Historic Market Share by Regions (2016-2021)
2.2.3 Tigecycline Drug Forecasted Market Size by Regions (2022-2027)
2.3 Tigecycline Drug Industry Dynamic
2.3.1 Tigecycline Drug Market Trends
2.3.2 Tigecycline Drug Market Drivers
2.3.3 Tigecycline Drug Market Challenges
2.3.4 Tigecycline Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tigecycline Drug Players by Revenue
3.1.1 Global Top Tigecycline Drug Players by Revenue (2016-2021)
3.1.2 Global Tigecycline Drug Revenue Market Share by Players (2016-2021)
3.2 Global Tigecycline Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Tigecycline Drug Revenue
3.4 Global Tigecycline Drug Market Concentration Ratio
3.4.1 Global Tigecycline Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tigecycline Drug Revenue in 2020
3.5 Tigecycline Drug Key Players Head office and Area Served
3.6 Key Players Tigecycline Drug Product Solution and Service
3.7 Date of Enter into Tigecycline Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tigecycline Drug Breakdown Data by Type
4.1 Global Tigecycline Drug Historic Market Size by Type (2016-2021)
4.2 Global Tigecycline Drug Forecasted Market Size by Type (2022-2027)
5 Tigecycline Drug Breakdown Data by Application
5.1 Global Tigecycline Drug Historic Market Size by Application (2016-2021)
5.2 Global Tigecycline Drug Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Tigecycline Drug Market Size (2016-2027)
6.2 North America Tigecycline Drug Market Size by Type
6.2.1 North America Tigecycline Drug Market Size by Type (2016-2021)
6.2.2 North America Tigecycline Drug Market Size by Type (2022-2027)
6.2.3 North America Tigecycline Drug Market Size by Type (2016-2027)
6.3 North America Tigecycline Drug Market Size by Application
6.3.1 North America Tigecycline Drug Market Size by Application (2016-2021)
6.3.2 North America Tigecycline Drug Market Size by Application (2022-2027)
6.3.3 North America Tigecycline Drug Market Size by Application (2016-2027)
6.4 North America Tigecycline Drug Market Size by Country
6.4.1 North America Tigecycline Drug Market Size by Country (2016-2021)
6.4.2 North America Tigecycline Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Tigecycline Drug Market Size (2016-2027)
7.2 Europe Tigecycline Drug Market Size by Type
7.2.1 Europe Tigecycline Drug Market Size by Type (2016-2021)
7.2.2 Europe Tigecycline Drug Market Size by Type (2022-2027)
7.2.3 Europe Tigecycline Drug Market Size by Type (2016-2027)
7.3 Europe Tigecycline Drug Market Size by Application
7.3.1 Europe Tigecycline Drug Market Size by Application (2016-2021)
7.3.2 Europe Tigecycline Drug Market Size by Application (2022-2027)
7.3.3 Europe Tigecycline Drug Market Size by Application (2016-2027)
7.4 Europe Tigecycline Drug Market Size by Country
7.4.1 Europe Tigecycline Drug Market Size by Country (2016-2021)
7.4.2 Europe Tigecycline Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Tigecycline Drug Market Size (2016-2027)
8.2 Asia-Pacific Tigecycline Drug Market Size by Type
8.2.1 Asia-Pacific Tigecycline Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Tigecycline Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Tigecycline Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Tigecycline Drug Market Size by Application
8.3.1 Asia-Pacific Tigecycline Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Tigecycline Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Tigecycline Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Tigecycline Drug Market Size by Region
8.4.1 Asia-Pacific Tigecycline Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Tigecycline Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Tigecycline Drug Market Size (2016-2027)
9.2 Latin America Tigecycline Drug Market Size by Type
9.2.1 Latin America Tigecycline Drug Market Size by Type (2016-2021)
9.2.2 Latin America Tigecycline Drug Market Size by Type (2022-2027)
9.2.3 Latin America Tigecycline Drug Market Size by Type (2016-2027)
9.3 Latin America Tigecycline Drug Market Size by Application
9.3.1 Latin America Tigecycline Drug Market Size by Application (2016-2021)
9.3.2 Latin America Tigecycline Drug Market Size by Application (2022-2027)
9.3.3 Latin America Tigecycline Drug Market Size by Application (2016-2027)
9.4 Latin America Tigecycline Drug Market Size by Country
9.4.1 Latin America Tigecycline Drug Market Size by Country (2016-2021)
9.4.2 Latin America Tigecycline Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tigecycline Drug Market Size (2016-2027)
10.2 Middle East & Africa Tigecycline Drug Market Size by Type
10.2.1 Middle East & Africa Tigecycline Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Tigecycline Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Tigecycline Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Tigecycline Drug Market Size by Application
10.3.1 Middle East & Africa Tigecycline Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Tigecycline Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Tigecycline Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Tigecycline Drug Market Size by Country
10.4.1 Middle East & Africa Tigecycline Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Tigecycline Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Tigecycline Drug Introduction
11.1.4 Pfizer Revenue in Tigecycline Drug Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Sandoz
11.2.1 Sandoz Company Details
11.2.2 Sandoz Business Overview
11.2.3 Sandoz Tigecycline Drug Introduction
11.2.4 Sandoz Revenue in Tigecycline Drug Business (2016-2021)
11.2.5 Sandoz Recent Development
11.3 Apotex
11.3.1 Apotex Company Details
11.3.2 Apotex Business Overview
11.3.3 Apotex Tigecycline Drug Introduction
11.3.4 Apotex Revenue in Tigecycline Drug Business (2016-2021)
11.3.5 Apotex Recent Development
11.4 Fresenius Kabi
11.4.1 Fresenius Kabi Company Details
11.4.2 Fresenius Kabi Business Overview
11.4.3 Fresenius Kabi Tigecycline Drug Introduction
11.4.4 Fresenius Kabi Revenue in Tigecycline Drug Business (2016-2021)
11.4.5 Fresenius Kabi Recent Development
11.5 Accord Healthcare
11.5.1 Accord Healthcare Company Details
11.5.2 Accord Healthcare Business Overview
11.5.3 Accord Healthcare Tigecycline Drug Introduction
11.5.4 Accord Healthcare Revenue in Tigecycline Drug Business (2016-2021)
11.5.5 Accord Healthcare Recent Development
11.6 Amneal
11.6.1 Amneal Company Details
11.6.2 Amneal Business Overview
11.6.3 Amneal Tigecycline Drug Introduction
11.6.4 Amneal Revenue in Tigecycline Drug Business (2016-2021)
11.6.5 Amneal Recent Development
11.7 Zhejiang Hisun Pharmaceutical
11.7.1 Zhejiang Hisun Pharmaceutical Company Details
11.7.2 Zhejiang Hisun Pharmaceutical Business Overview
11.7.3 Zhejiang Hisun Pharmaceutical Tigecycline Drug Introduction
11.7.4 Zhejiang Hisun Pharmaceutical Revenue in Tigecycline Drug Business (2016-2021)
11.7.5 Zhejiang Hisun Pharmaceutical Recent Development
11.8 Nanjing Hicin Pharmaceutical
11.8.1 Nanjing Hicin Pharmaceutical Company Details
11.8.2 Nanjing Hicin Pharmaceutical Business Overview
11.8.3 Nanjing Hicin Pharmaceutical Tigecycline Drug Introduction
11.8.4 Nanjing Hicin Pharmaceutical Revenue in Tigecycline Drug Business (2016-2021)
11.8.5 Nanjing Hicin Pharmaceutical Recent Development
11.9 CTTQ Pharma
11.9.1 CTTQ Pharma Company Details
11.9.2 CTTQ Pharma Business Overview
11.9.3 CTTQ Pharma Tigecycline Drug Introduction
11.9.4 CTTQ Pharma Revenue in Tigecycline Drug Business (2016-2021)
11.9.5 CTTQ Pharma Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Tigecycline Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of TYGACIL
Table 3. Key Players of Generic
Table 4. Global Tigecycline Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Tigecycline Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Tigecycline Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Tigecycline Drug Market Share by Regions (2016-2021)
Table 8. Global Tigecycline Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Tigecycline Drug Market Share by Regions (2022-2027)
Table 10. Tigecycline Drug Market Trends
Table 11. Tigecycline Drug Market Drivers
Table 12. Tigecycline Drug Market Challenges
Table 13. Tigecycline Drug Market Restraints
Table 14. Global Tigecycline Drug Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Tigecycline Drug Market Share by Players (2016-2021)
Table 16. Global Top Tigecycline Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tigecycline Drug as of 2020)
Table 17. Ranking of Global Top Tigecycline Drug Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Tigecycline Drug Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Tigecycline Drug Product Solution and Service
Table 21. Date of Enter into Tigecycline Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Tigecycline Drug Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Tigecycline Drug Revenue Market Share by Type (2016-2021)
Table 25. Global Tigecycline Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Tigecycline Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Tigecycline Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Tigecycline Drug Revenue Market Share by Application (2016-2021)
Table 29. Global Tigecycline Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Tigecycline Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Tigecycline Drug Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Tigecycline Drug Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Tigecycline Drug Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Tigecycline Drug Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Tigecycline Drug Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Tigecycline Drug Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Tigecycline Drug Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Tigecycline Drug Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Tigecycline Drug Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Tigecycline Drug Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Tigecycline Drug Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Tigecycline Drug Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Tigecycline Drug Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Tigecycline Drug Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Tigecycline Drug Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Tigecycline Drug Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Tigecycline Drug Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Tigecycline Drug Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Tigecycline Drug Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Tigecycline Drug Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Tigecycline Drug Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Tigecycline Drug Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Tigecycline Drug Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Tigecycline Drug Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Tigecycline Drug Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Tigecycline Drug Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Tigecycline Drug Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Tigecycline Drug Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Tigecycline Drug Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Tigecycline Drug Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Tigecycline Drug Product
Table 64. Pfizer Revenue in Tigecycline Drug Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Sandoz Company Details
Table 67. Sandoz Business Overview
Table 68. Sandoz Tigecycline Drug Product
Table 69. Sandoz Revenue in Tigecycline Drug Business (2016-2021) & (US$ Million)
Table 70. Sandoz Recent Development
Table 71. Apotex Company Details
Table 72. Apotex Business Overview
Table 73. Apotex Tigecycline Drug Product
Table 74. Apotex Revenue in Tigecycline Drug Business (2016-2021) & (US$ Million)
Table 75. Apotex Recent Development
Table 76. Fresenius Kabi Company Details
Table 77. Fresenius Kabi Business Overview
Table 78. Fresenius Kabi Tigecycline Drug Product
Table 79. Fresenius Kabi Revenue in Tigecycline Drug Business (2016-2021) & (US$ Million)
Table 80. Fresenius Kabi Recent Development
Table 81. Accord Healthcare Company Details
Table 82. Accord Healthcare Business Overview
Table 83. Accord Healthcare Tigecycline Drug Product
Table 84. Accord Healthcare Revenue in Tigecycline Drug Business (2016-2021) & (US$ Million)
Table 85. Accord Healthcare Recent Development
Table 86. Amneal Company Details
Table 87. Amneal Business Overview
Table 88. Amneal Tigecycline Drug Product
Table 89. Amneal Revenue in Tigecycline Drug Business (2016-2021) & (US$ Million)
Table 90. Amneal Recent Development
Table 91. Zhejiang Hisun Pharmaceutical Company Details
Table 92. Zhejiang Hisun Pharmaceutical Business Overview
Table 93. Zhejiang Hisun Pharmaceutical Tigecycline Drug Product
Table 94. Zhejiang Hisun Pharmaceutical Revenue in Tigecycline Drug Business (2016-2021) & (US$ Million)
Table 95. Zhejiang Hisun Pharmaceutical Recent Development
Table 96. Nanjing Hicin Pharmaceutical Company Details
Table 97. Nanjing Hicin Pharmaceutical Business Overview
Table 98. Nanjing Hicin Pharmaceutical Revenue in Tigecycline Drug Business (2016-2021) & (US$ Million)
Table 99. Nanjing Hicin Pharmaceutical Recent Development
Table 100. CTTQ Pharma Company Details
Table 101. CTTQ Pharma Business Overview
Table 102. CTTQ Pharma Tigecycline Drug Product
Table 103. CTTQ Pharma Revenue in Tigecycline Drug Business (2016-2021) & (US$ Million)
Table 104. CTTQ Pharma Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tigecycline Drug Market Share by Type: 2020 VS 2027
Figure 2. TYGACIL Features
Figure 3. Generic Features
Figure 4. Global Tigecycline Drug Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Drug store Case Studies
Figure 7. Tigecycline Drug Report Years Considered
Figure 8. Global Tigecycline Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Tigecycline Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Tigecycline Drug Market Share by Regions: 2020 VS 2027
Figure 11. Global Tigecycline Drug Market Share by Regions (2022-2027)
Figure 12. Global Tigecycline Drug Market Share by Players in 2020
Figure 13. Global Top Tigecycline Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tigecycline Drug as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Tigecycline Drug Revenue in 2020
Figure 15. Global Tigecycline Drug Revenue Market Share by Type (2016-2021)
Figure 16. Global Tigecycline Drug Revenue Market Share by Type (2022-2027)
Figure 17. North America Tigecycline Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Tigecycline Drug Market Share by Type (2016-2027)
Figure 19. North America Tigecycline Drug Market Share by Application (2016-2027)
Figure 20. North America Tigecycline Drug Market Share by Country (2016-2027)
Figure 21. United States Tigecycline Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Tigecycline Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Tigecycline Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Tigecycline Drug Market Share by Type (2016-2027)
Figure 25. Europe Tigecycline Drug Market Share by Application (2016-2027)
Figure 26. Europe Tigecycline Drug Market Share by Country (2016-2027)
Figure 27. Germany Tigecycline Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Tigecycline Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Tigecycline Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Tigecycline Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Tigecycline Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Tigecycline Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Tigecycline Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Tigecycline Drug Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Tigecycline Drug Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Tigecycline Drug Market Share by Region (2016-2027)
Figure 37. China Tigecycline Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Tigecycline Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Tigecycline Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Tigecycline Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Tigecycline Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Tigecycline Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Tigecycline Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Tigecycline Drug Market Share by Type (2016-2027)
Figure 45. Latin America Tigecycline Drug Market Share by Application (2016-2027)
Figure 46. Latin America Tigecycline Drug Market Share by Country (2016-2027)
Figure 47. Mexico Tigecycline Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Tigecycline Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Tigecycline Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Tigecycline Drug Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Tigecycline Drug Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Tigecycline Drug Market Share by Country (2016-2027)
Figure 53. Turkey Tigecycline Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Tigecycline Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Tigecycline Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Pfizer Revenue Growth Rate in Tigecycline Drug Business (2016-2021)
Figure 57. Sandoz Revenue Growth Rate in Tigecycline Drug Business (2016-2021)
Figure 58. Apotex Revenue Growth Rate in Tigecycline Drug Business (2016-2021)
Figure 59. Fresenius Kabi Revenue Growth Rate in Tigecycline Drug Business (2016-2021)
Figure 60. Accord Healthcare Revenue Growth Rate in Tigecycline Drug Business (2016-2021)
Figure 61. Amneal Revenue Growth Rate in Tigecycline Drug Business (2016-2021)
Figure 62. Zhejiang Hisun Pharmaceutical Revenue Growth Rate in Tigecycline Drug Business (2016-2021)
Figure 63. Nanjing Hicin Pharmaceutical Revenue Growth Rate in Tigecycline Drug Business (2016-2021)
Figure 64. CTTQ Pharma Revenue Growth Rate in Tigecycline Drug Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
チゲサイクリンのグローバル市場調査 2019年 The global Tigecycline market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Tigecycline volume and value at global level, regional level and company level. From a global perspective, this report represen…- チゲサイクリンのグローバル市場調査 2019年 The global Tigecycline market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Tigecycline volume and value at global level, regional level and company level. From a global perspective, this report represen…
- 世界のアンブリセンタン薬市場規模・現状・予測（2021年-2027年） Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name Pulmonext by MSN labs) is a drug indicated for use in the treatment of pulmonary hypertension. Market Analysis and Insights: Global Ambrisentan Drug Market The global Ambrisentan Drug market size is projected to reach …
- 世界のスニチニブ薬市場規模・現状・予測（2021年-2027年） Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on J…
- 世界のデシタビン薬市場規模・現状・予測（2021年-2027年） Decitabine (trade name Dacogen), or 5-aza-2'-deoxycytidine, acts as an Nucleic Acid Synthesis Inhibitor. It is a drug for the treatment of myelodysplastic syndromes, a class of conditions where certain blood cells are dysfunctional, and for acute myeloid leukemia (AML). Market Analysis and Insights:…